FDA halts trials of Amgen drug in children after 14-year-old dies
The Food and Drug Administration said Tuesday it has stopped all pediatric clinical trials of Amgen Inc's Sensipar after the death of a 14-year-old patient taking part in a study of the drug
Tags:
FDA halts trials of Amgen drug in children after 14-year-old dies,
Food And Drug Administration Latest News